Simultaneous Targeting of Aurora Kinases and BCR-Abl Kinase by the Small Molecule Inhibitor PHA-739358 Is Effective Against Imatinib-Resistant BCR-ABL Mutations Including T315I
Blood - United States
doi 10.1182/blood-2007-09-113175
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2008
Authors
Publisher
American Society of Hematology